<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="68891">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02005640</url>
  </required_header>
  <id_info>
    <org_study_id>MSCT-TAVI 1</org_study_id>
    <nct_id>NCT02005640</nct_id>
  </id_info>
  <brief_title>Transcatheter Heart Valve (THV) Sizing and Leakage After Transcatheter Aortic Valve Implantation (TAVI) Before and After Establishing Routine Preprocedure Multi Slice Computerized Tomography (MSCT) Aortic Assessment. A Retrospective Registry Study</brief_title>
  <official_title>Transcatheter Heart Valve (THV) Sizing and Leakage After Transcatheter Aortic Valve Implantation (TAVI) Before and After Establishing Routine Preprocedure Multi Slice Computerized Tomography (MSCT) Aortic Assessment. A Retrospective Registry Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Aarhus University Hospital Skejby</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Aarhus University Hospital Skejby</source>
  <oversight_info>
    <authority>Denmark: Danish Dataprotection Agency</authority>
    <authority>Denmark: National Board of Health</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of this study is to evaluate the effect of annular sizing strategy (MDCT
      versus TEE) in transcatheter aortic valve implantation on the prevalence and severity of
      paravalvular regurgitation.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>December 2011</start_date>
  <completion_date type="Actual">September 2012</completion_date>
  <primary_completion_date type="Actual">September 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Time Perspective: Retrospective</study_design>
  <primary_outcome>
    <measure>Rate of no/ mild paravalvular leakage before and after introduction of routing preoperative MSCT</measure>
    <time_frame>1 week to 3 months post-TAVI</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <primary_outcome>
    <measure>MSCT vs. echocardiographic aortic valve sizing before TAVI</measure>
    <time_frame>time of TAVI</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <primary_outcome>
    <measure>THV size before and after introduction of routing preoperative MSCT</measure>
    <time_frame>time of TAVI</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">150</enrollment>
  <condition>Aortic Stenosis</condition>
  <arm_group>
    <arm_group_label>MSCT-based prothesis sizing</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Echocardiographic-based prothesis sizing</arm_group_label>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Primary analysis will be done in patients with a successful THV implantation and
        availability of high quality echocardiographic assessment and in the post routing MSCT
        group on the availability of a high quality MSCT scan.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients implanted with a THV at Aarhus University Hospital

        Exclusion Criteria:

          -  Learning curve patients (the first 40 patients implanted with a THV device at Aarhus
             University Hospital, Skejby).
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Department of Cardiology and Cardiothoracic Surgery, Aarhus University Hospital</name>
      <address>
        <city>Aarhus N</city>
        <zip>8000</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>December 2013</verification_date>
  <lastchanged_date>December 3, 2013</lastchanged_date>
  <firstreceived_date>December 3, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Aarhus University Hospital Skejby</investigator_affiliation>
    <investigator_full_name>Jens Flensted Lassen</investigator_full_name>
    <investigator_title>M.D., D.M.Sc.</investigator_title>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Aortic Valve Stenosis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
